Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

DXR vs TFX vs HOLX vs BDX vs BAX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DXR
Daxor Corporation

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$56M
5Y Perf.-27.5%
TFX
Teleflex Incorporated

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$5.83B
5Y Perf.-63.7%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%
BDX
Becton, Dickinson and Company

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$55.53B
5Y Perf.+3.0%
BAX
Baxter International Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$9.04B
5Y Perf.-80.5%

DXR vs TFX vs HOLX vs BDX vs BAX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DXR logoDXR
TFX logoTFX
HOLX logoHOLX
BDX logoBDX
BAX logoBAX
IndustryMedical - Instruments & SuppliesMedical - Instruments & SuppliesMedical - Instruments & SuppliesMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$56M$5.83B$16.97B$55.53B$9.04B
Revenue (TTM)$868K$2.81B$4.13B$21.36B$11.32B
Net Income (TTM)$3M$-1.01B$544M$1.14B$-1.10B
Gross Margin91.4%53.3%52.8%46.5%30.1%
Operating Margin5.4%5.6%17.5%10.6%-2.7%
Forward P/E87.8x19.6x17.2x12.3x9.2x
Total Debt$730K$2.73B$2.63B$19.18B$10.00B
Cash & Equiv.$393M$1.96B$851M$1.97B

DXR vs TFX vs HOLX vs BDX vs BAXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DXR
TFX
HOLX
BDX
BAX
StockMay 20May 26Return
Daxor Corporation (DXR)10072.5-27.5%
Teleflex Incorporat… (TFX)10036.3-63.7%
Hologic, Inc. (HOLX)100142.6+42.6%
Becton, Dickinson a… (BDX)100103.0+3.0%
Baxter Internationa… (BAX)10019.5-80.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: DXR vs TFX vs HOLX vs BDX vs BAX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DXR and BDX are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Becton, Dickinson and Company is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. BAX also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
DXR
Daxor Corporation
The Quality Compounder

DXR carries the broadest edge in this set and is the clearest fit for quality and stability.

  • 401.5% margin vs TFX's -35.9%
  • Beta 0.33 vs BAX's 1.37, lower leverage
  • 9.8% ROA vs TFX's -13.9%, ROIC 1.3% vs 3.4%
Best for: quality and stability
TFX
Teleflex Incorporated
The Healthcare Pick

TFX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
HOLX
Hologic, Inc.
The Long-Run Compounder

HOLX is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 124.3% 10Y total return vs BDX's 80.2%
  • Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
  • Beta 0.41, current ratio 3.75x
Best for: long-term compounding and sleep-well-at-night
BDX
Becton, Dickinson and Company
The Income Pick

BDX is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 1 yrs, beta 0.66, yield 2.7%
  • Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
  • 8.2% revenue growth vs DXR's -93.8%
  • 2.7% yield, 1-year raise streak, vs BAX's 3.9%, (2 stocks pay no dividend)
Best for: income & stability and growth exposure
BAX
Baxter International Inc.
The Value Play

BAX ranks third and is worth considering specifically for value.

  • Lower P/E (9.2x vs 12.3x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthBDX logoBDX8.2% revenue growth vs DXR's -93.8%
ValueBAX logoBAXLower P/E (9.2x vs 12.3x)
Quality / MarginsDXR logoDXR401.5% margin vs TFX's -35.9%
Stability / SafetyDXR logoDXRBeta 0.33 vs BAX's 1.37, lower leverage
DividendsBDX logoBDX2.7% yield, 1-year raise streak, vs BAX's 3.9%, (2 stocks pay no dividend)
Momentum (1Y)BDX logoBDX+51.8% vs BAX's -41.8%
Efficiency (ROA)DXR logoDXR9.8% ROA vs TFX's -13.9%, ROIC 1.3% vs 3.4%

DXR vs TFX vs HOLX vs BDX vs BAX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DXRDaxor Corporation

Segment breakdown not available.

TFXTeleflex Incorporated
FY 2025
Vascular Access
46.1%$918M
Interventional
32.5%$648M
Surgical
21.0%$418M
Other
0.5%$9M
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M
BDXBecton, Dickinson and Company
FY 2025
Medical
52.5%$11.5B
Interventional
23.9%$5.2B
Life Sciences
23.7%$5.2B
BAXBaxter International Inc.
FY 2025
Medical Products And Therapies
48.8%$5.3B
Healthcare Systems and Technologies
28.3%$3.1B
Pharmaceuticals
22.9%$2.5B

DXR vs TFX vs HOLX vs BDX vs BAX — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDXRLAGGINGTFX

Income & Cash Flow (Last 12 Months)

DXR leads this category, winning 4 of 6 comparable metrics.

BDX is the larger business by revenue, generating $21.4B annually — 24618.1x DXR's $867,859. DXR is the more profitable business, keeping 4.0% of every revenue dollar as net income compared to TFX's -35.9%. On growth, BAX holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
RevenueTrailing 12 months$867,859$2.8B$4.1B$21.4B$11.3B
EBITDAEarnings before interest/tax$7M$280M$974M$4.2B$671M
Net IncomeAfter-tax profit$3M-$1.0B$544M$1.1B-$1.1B
Free Cash FlowCash after capex-$5M$249M$1000M$3.1B$501M
Gross MarginGross profit ÷ Revenue+91.4%+53.3%+52.8%+46.5%+30.1%
Operating MarginEBIT ÷ Revenue+5.4%+5.6%+17.5%+10.6%-2.7%
Net MarginNet income ÷ Revenue+4.0%-35.9%+13.2%+5.3%-9.7%
FCF MarginFCF ÷ Revenue-5.4%+8.9%+24.2%+14.7%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year-74.4%-21.8%+2.5%-10.6%+2.9%
EPS Growth (YoY)Latest quarter vs prior year+78.2%-108.7%-9.2%-2.0%-112.0%
DXR leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

BAX leads this category, winning 3 of 6 comparable metrics.

At 26.3x trailing earnings, BDX trades at a 70% valuation discount to DXR's 87.8x P/E. On an enterprise value basis, BDX's 14.7x EV/EBITDA is more attractive than DXR's 27.7x.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
Market CapShares × price$56M$5.8B$17.0B$55.5B$9.0B
Enterprise ValueMkt cap + debt − cash$57M$8.2B$17.6B$73.9B$17.1B
Trailing P/EPrice ÷ TTM EPS87.82x-6.50x30.53x26.29x-10.01x
Forward P/EPrice ÷ next-FY EPS est.19.59x17.21x12.27x9.17x
PEG RatioP/E ÷ EPS growth rate1.59x
EV / EBITDAEnterprise value multiple27.70x18.82x17.39x14.65x25.37x
Price / SalesMarket cap ÷ Revenue26.42x2.93x4.14x2.54x0.80x
Price / BookPrice ÷ Book value/share1.31x1.88x3.43x1.73x1.47x
Price / FCFMarket cap ÷ FCF2190.99x23.75x18.44x20.80x27.99x
BAX leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

HOLX leads this category, winning 5 of 9 comparable metrics.

HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-28 for TFX. DXR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to BAX's 1.64x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs BAX's 5/9, reflecting strong financial health.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
ROE (TTM)Return on equity+10.1%-28.3%+11.0%+4.5%-16.5%
ROA (TTM)Return on assets+9.8%-13.9%+6.1%+2.1%-5.4%
ROICReturn on invested capital+1.3%+3.4%+9.4%+4.3%-1.4%
ROCEReturn on capital employed+1.7%+4.0%+8.8%+5.4%-1.7%
Piotroski ScoreFundamental quality 0–955775
Debt / EquityFinancial leverage0.02x0.87x0.52x0.76x1.64x
Net DebtTotal debt minus cash$729,966$2.3B$667M$18.3B$8.0B
Cash & Equiv.Liquid assets$393M$2.0B$851M$2.0B
Total DebtShort + long-term debt$729,966$2.7B$2.6B$19.2B$10.0B
Interest CoverageEBIT ÷ Interest expense-6.11x-2.02x8.00x4.09x-0.83x
HOLX leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BDX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in BDX five years ago would be worth $11,693 today (with dividends reinvested), compared to $2,566 for BAX. Over the past 12 months, BDX leads with a +51.8% total return vs BAX's -41.8%. The 3-year compound annual growth rate (CAGR) favors BDX at 1.6% vs BAX's -24.1% — a key indicator of consistent wealth creation.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
YTD ReturnYear-to-date-32.7%+7.9%+1.9%+0.7%-10.2%
1-Year ReturnPast 12 months+29.3%+9.0%+37.1%+51.8%-41.8%
3-Year ReturnCumulative with dividends-17.8%-47.6%-8.5%+5.0%-56.3%
5-Year ReturnCumulative with dividends+3.3%-66.4%+15.8%+16.9%-74.3%
10-Year ReturnCumulative with dividends+21.9%-10.3%+124.3%+80.2%-42.4%
CAGR (3Y)Annualised 3-year return-6.3%-19.4%-2.9%+1.6%-24.1%
BDX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DXR and HOLX each lead in 1 of 2 comparable metrics.

DXR is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than BAX's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs BAX's 53.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
Beta (5Y)Sensitivity to S&P 5000.33x1.06x0.41x0.66x1.37x
52-Week HighHighest price in past year$14.76$139.63$76.04$205.52$32.68
52-Week LowLowest price in past year$7.13$100.18$52.81$100.31$15.73
% of 52W HighCurrent price vs 52-week peak+65.4%+94.3%+100.0%+74.6%+53.6%
RSI (14)Momentum oscillator 0–10048.048.569.132.244.0
Avg Volume (50D)Average daily shares traded11K884K10.0M2.5M8.7M
Evenly matched — DXR and HOLX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BDX and BAX each lead in 1 of 2 comparable metrics.

Analyst consensus: TFX as "Buy", HOLX as "Hold", BDX as "Buy", BAX as "Hold". Consensus price targets imply 12.8% upside for BAX (target: $20) vs 0.4% for TFX (target: $132). For income investors, BAX offers the higher dividend yield at 3.87% vs TFX's 1.02%.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…HOLX logoHOLXHologic, Inc.BDX logoBDXBecton, Dickinson…BAX logoBAXBaxter Internatio…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyHold
Price TargetConsensus 12-month target$132.20$79.00$172.85$19.75
# AnalystsCovering analysts29423336
Dividend YieldAnnual dividend ÷ price+1.0%+2.7%+3.9%
Dividend StreakConsecutive years of raises0010
Dividend / ShareAnnual DPS$1.35$4.17$0.68
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.1%+4.4%+1.8%0.0%
Evenly matched — BDX and BAX each lead in 1 of 2 comparable metrics.
Key Takeaway

DXR leads in 1 of 6 categories (Income & Cash Flow). BAX leads in 1 (Valuation Metrics). 2 tied.

Best OverallDaxor Corporation (DXR)Leads 1 of 6 categories
Loading custom metrics...

DXR vs TFX vs HOLX vs BDX vs BAX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is DXR or TFX or HOLX or BDX or BAX a better buy right now?

For growth investors, Becton, Dickinson and Company (BDX) is the stronger pick with 8.

2% revenue growth year-over-year, versus -93. 8% for Daxor Corporation (DXR). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DXR or TFX or HOLX or BDX or BAX?

On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.

3x versus Daxor Corporation at 87. 8x. On forward P/E, Baxter International Inc. is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — DXR or TFX or HOLX or BDX or BAX?

Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +16.

9%, compared to -74. 3% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus BAX's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DXR or TFX or HOLX or BDX or BAX?

By beta (market sensitivity over 5 years), Daxor Corporation (DXR) is the lower-risk stock at 0.

33β versus Baxter International Inc. 's 1. 37β — meaning BAX is approximately 317% more volatile than DXR relative to the S&P 500. On balance sheet safety, Daxor Corporation (DXR) carries a lower debt/equity ratio of 2% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DXR or TFX or HOLX or BDX or BAX?

By revenue growth (latest reported year), Becton, Dickinson and Company (BDX) is pulling ahead at 8.

2% versus -93. 8% for Daxor Corporation (DXR). On earnings-per-share growth, the picture is similar: Daxor Corporation grew EPS 81. 5% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Over a 3-year CAGR, BDX leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DXR or TFX or HOLX or BDX or BAX?

Daxor Corporation (DXR) is the more profitable company, earning 25.

2% net margin versus -45. 4% for Teleflex Incorporated — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXR leads at 29. 2% versus -2. 7% for BAX. At the gross margin level — before operating expenses — DXR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DXR or TFX or HOLX or BDX or BAX more undervalued right now?

On forward earnings alone, Baxter International Inc.

(BAX) trades at 9. 2x forward P/E versus 19. 6x for Teleflex Incorporated — 10. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAX: 12. 8% to $19. 75.

08

Which pays a better dividend — DXR or TFX or HOLX or BDX or BAX?

In this comparison, BAX (3.

9% yield), BDX (2. 7% yield), TFX (1. 0% yield) pay a dividend. DXR, HOLX do not pay a meaningful dividend and should not be held primarily for income.

09

Is DXR or TFX or HOLX or BDX or BAX better for a retirement portfolio?

For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

66), 2. 7% yield). Both have compounded well over 10 years (BDX: +80. 2%, BAX: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DXR and TFX and HOLX and BDX and BAX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DXR is a small-cap quality compounder stock; TFX is a small-cap quality compounder stock; HOLX is a mid-cap quality compounder stock; BDX is a mid-cap quality compounder stock; BAX is a small-cap income-oriented stock. TFX, BDX, BAX pay a dividend while DXR, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

DXR

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 240%
Run This Screen
Stocks Like

TFX

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 31%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Stocks Like

BDX

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 1.0%
Run This Screen
Stocks Like

BAX

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 18%
  • Dividend Yield > 1.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DXR and TFX and HOLX and BDX and BAX on the metrics below

Revenue Growth>
%
(DXR: -74.4% · TFX: -21.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.